ZOLINZA DIN 02327619
Health Canada record
| Active ingredient(s) | VORINOSTAT 100 MG |
|---|---|
| Dosage form | Capsule |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L01XH01 VORINOSTAT |
| Original market date | 29-Jun-2009 |
| Current status date | 29-Jun-2009 |
| Source | Health Canada DPD |
Establishment licence of the holder
Merck Canada Inc — licence 101380, currently licensed, last inspection rating C (2023-07-17).
No Canadian shortage report is currently matched to this DIN.
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 10246 | 2009-06-11 | New Drug Submission (NDS) |
International API supply for VORINOSTAT
1 active FDA Drug Master Files.
Request a quote for ZOLINZA